The targets for Q2 were continuing to be negotiated. We are now going to make sure we have more than enough vaccine to allow at least every Canadian to have one shot. That number, hopefully, will continue to rise in Q2 because, as I told you, my work every day is to press suppliers for additional vaccines.
What will we see at the very least? We'll see 17.8 million doses of Pfizer in Q2, 12.3 million doses of Moderna in Q2, and AstraZeneca doses coming from the Serum Institute and under our bilateral APA.
It is very important to remember that we will continue to press both suppliers and also jurisdictions. Our discussions with the United States, for example, are ongoing, and we hope we will be able to pull additional doses from that source as well.